3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
2
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Severe Combined Immunodeficiency
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Mucopolysaccharidosis I
1
Meningeal Neoplasms
1
Meningeal Carcinomatosis
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Genetic Predisposition to Disease
1
Esthesioneuroblastoma, Olfactory
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Interventions
Filgrastim
11
Temozolomide
9
Melphalan
9
Cyclophosphamide
9
Radiotherapy
7
Busulfan
7
Magnetic Resonance Spectroscopy
6
Rituximab
5
Psychiatric Rehabilitation
5
Methotrexate
5
Etoposide
5
Cytarabine
5
Carboplatin
5
sargramostim
4
fludarabine
4
etoposide phosphate
4
Thiotepa
4
Nivolumab
4
Methylprednisolone
4
Flow Cytometry
4
Alemtuzumab
4
Vincristine
3
Topotecan
3
Specimen Handling
3
Peripheral Blood Stem Cell Transplantation
3
Pemetrexed
3
Granulocyte Colony-Stimulating Factor
3
Early Intervention, Educational
3
Drug Therapy
3
Dexamethasone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Phlebotomy
×
CNS
×
Clear all
NCT01540175
2015-07-14
IROPAST
St. Jude Children's Research Hospital
Completed
31 enrolled